263 related articles for article (PubMed ID: 27338635)
1. Reclassification of rhabdoid tumor and pediatric undifferentiated/unclassified sarcoma with complete loss of SMARCB1/INI1 protein expression: three subtypes of rhabdoid tumor according to their histological features.
Kohashi K; Tanaka Y; Kishimoto H; Yamamoto H; Yamada Y; Taguchi T; Iwamoto Y; Oda Y
Mod Pathol; 2016 Oct; 29(10):1232-42. PubMed ID: 27338635
[TBL] [Abstract][Full Text] [Related]
2. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
4. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
[TBL] [Abstract][Full Text] [Related]
5. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor.
Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X
Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041
[TBL] [Abstract][Full Text] [Related]
6. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.
Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J
Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370
[TBL] [Abstract][Full Text] [Related]
7. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.
Perry A; Fuller CE; Judkins AR; Dehner LP; Biegel JA
Mod Pathol; 2005 Jul; 18(7):951-8. PubMed ID: 15761491
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
Ramalingam P; Croce S; McCluggage WG
Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
[TBL] [Abstract][Full Text] [Related]
9. Loss of BRG1 (
Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors.
Hoot AC; Russo P; Judkins AR; Perlman EJ; Biegel JA
Am J Surg Pathol; 2004 Nov; 28(11):1485-91. PubMed ID: 15489652
[TBL] [Abstract][Full Text] [Related]
11. Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.
Kohashi K; Yamamoto H; Kumagai R; Yamada Y; Hotokebuchi Y; Taguchi T; Iwamoto Y; Oda Y
Mod Pathol; 2014 Jun; 27(6):832-9. PubMed ID: 24287458
[TBL] [Abstract][Full Text] [Related]
12. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study.
Espinosa I; D'Angelo E; De Brot L; Prat J
Hum Pathol; 2023 May; 135():1-10. PubMed ID: 36863690
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
[TBL] [Abstract][Full Text] [Related]
14. Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome.
Baker TG; Lyons MJ; Leddy L; Parham DM; Welsh CT
Pediatr Dev Pathol; 2021; 24(2):164-168. PubMed ID: 33470921
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic roles of SMARCB1/INI1 and its deficient tumors.
Kohashi K; Oda Y
Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176
[TBL] [Abstract][Full Text] [Related]
17. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas.
Kreiger PA; Judkins AR; Russo PA; Biegel JA; Lestini BJ; Assanasen C; Pawel BR
Mod Pathol; 2009 Jan; 22(1):142-50. PubMed ID: 18997735
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of atypical teratoid/rhabdoid tumor.
Oka H; Scheithauer BW
Neurol Med Chir (Tokyo); 1999 Jul; 39(7):510-7; discussion 517-8. PubMed ID: 10437379
[TBL] [Abstract][Full Text] [Related]
19. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior.
Cheng JX; Tretiakova M; Gong C; Mandal S; Krausz T; Taxy JB
Mod Pathol; 2008 Jun; 21(6):647-52. PubMed ID: 18327209
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization.
Kawai T; Ogata S; Nakashima H; Urabe S; Murakami I; Hiroshima K
Hum Pathol; 2019 Nov; 93():23-29. PubMed ID: 31445842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]